financetom
Business
financetom
/
Business
/
Texas AG probes proxy advisers Glass Lewis, ISS amid ESG backlash
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Texas AG probes proxy advisers Glass Lewis, ISS amid ESG backlash
Sep 16, 2025 6:34 PM

(Reuters) - Texas Attorney General Ken Paxton on Tuesday launched an investigation into proxy advisers Glass Lewis and Institutional Shareholder Services, alleging they may have misled institutional investors and public companies.

Glass Lewis and ISS, the two largest U.S. proxy advisory firms, analyze shareholder proposals and corporate governance issues and provide voting recommendations to institutional investors ahead of annual meetings.

Their guidance can influence votes on board elections, executive compensation and environmental or social resolutions.

"Proxy advisors play a massive role in shaping corporate governance decisions in our country, affecting tens of billions of dollars," Paxton said in a statement.

He said his office issued civil investigative demands to both firms to determine whether they violated Texas consumer-protection laws, including rules on disclosing material facts.

"Attorney General Paxton's press release mischaracterizes Glass Lewis's advice and business practices," a Glass Lewis spokesperson told Reuters in a statement, adding that the firm provides advice to "highly sophisticated institutional investors."

"Our clients are not in any way misled."

An ISS spokesperson said the firm was aware of the announcement and remained confident that it had complied with all applicable laws.

"(ISS) will vigorously defend itself from any allegations of wrongdoing," the spokesperson added.

REPUBLICAN PUSH AGAINST ESG

The investigation comes amid a broader Republican campaign against ESG, with critics arguing companies should prioritize shareholder returns over social or environmental goals.

Several companies this year have scaled back or ended diversity, equity, and inclusion programs with U.S. President Donald Trump having made eliminating such programs a priority.

Texas has been at the forefront of this pushback. In August, a federal judge issued a preliminary injunction blocking the Republican-run state from enforcing a first-of-its-kind state law restricting Glass Lewis and ISS from advising shareholders on ESG practices.

"Indeed, a federal district court in Texas has enjoined the Attorney General from targeting Glass Lewis for its constitutionally protected speech," the Glass Lewis spokesperson added.

Both firms have long drawn criticism for their influential voting recommendations, traditionally from corporate executives, but their guidance remains widely used by institutional investors.

Supporters say the advisers help investors navigate complex governance issues, distill lengthy filings and increase accountability on corporate boards.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved